Artemis Hospitals
| India | Turkey | Austria | |
| Gamma Knife | from $4,500 | from $6,300 | from $32,000 |
| Chemotherapy for breast cancer | from $3,500 | from $1,200 | from $15,000 |
| Actinium-225 Therapy | from $8,500 | from $22,955 | from $55,000 |
| Resection of glioblastoma | from $7,500 | from $14,400 | - |
| Halcyon | from $3,800 | from $5,400 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Glioblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
Handled more than 30,000 PET scans and 1,000 thyroid cancer patients – Dr. Borde brings deep nuclear medicine expertise to glioblastoma cases.
Dr. Kharya specializes in pediatric hematology-oncology and bone marrow transplants at Artemis Hospitals.
Dr. Sarat Chandra P specializes in oncology at Manipal Hospitals.
Head and Chief of Neurosurgery at BLK Super Speciality Hospital – specializes in complex brain and spine conditions.
The standard protocol for glioblastoma in India follows the Stupp Regimen. This involves maximal surgical resection followed by concurrent radiation and oral temozolomide chemotherapy. Treatment typically includes 60 Gy of radiation over 6 weeks. National accreditation bodies like NABH and JCI oversee these protocols in major Indian medical centers.
Bookimed Expert Insight: Data from major Indian networks like Apollo and Manipal show a high volume of over 1,000,000 patients annually. This high throughput allows surgeons like Dr. Raj Nagarkar to perform 50,000+ surgeries. Patients should note that while baseline protocols are standard, larger centers offer specialized equipment like the Halcyon system or Gamma Knife which are essential for precision in complex neuro-oncology cases.
Patient Consensus: Patients emphasize the importance of starting radiation within 4 weeks of surgery to ensure the best results. Many recommend seeking a second neurosurgical opinion before the first resection to ensure an aggressive but safe approach is planned.
Leading Indian oncology centers utilize neuronavigation systems and intraoperative MRI to maximize tumor resection while protecting healthy tissue. These facilities integrate 5-ALA fluorescence guidance to visualize tumor margins. Specialized neuro-robotic platforms and awake craniotomy with functional mapping help preserve motor and speech functions during complex glioblastoma surgeries.
Bookimed Expert Insight: Patient volume is a major quality indicator in India. Manipal Hospitals and Apollo Hospital Indraprastha serve over 1,000,000 patients annually each. This high volume allows surgeons to master specific technologies like robotic systems or Gamma Knife more rapidly than in lower-volume centers. When selecting a facility, focus on these high-capacity networks where surgeons often have experience from over 15,000 to 50,000 procedures.
Patient Consensus: Patients highlight that using 5-ALA dye and intraoperative MRI significantly helps clarify tumor edges. Many recommend confirming these tools are available during the initial consultation to ensure the most thorough surgery possible.
Patients in India can expect a median survival of 12 to 18 months for glioblastoma when receiving standard multimodal care. Outcomes align with international standards at major centers using the Stupp protocol. Younger patients with specific genetic markers like MGMT methylation may reach survival markers of 24 months.
Bookimed Expert Insight: While median survival remains consistent with global norms, India's edge lies in the rapid adoption of niche technologies like IBM Watson at Manipal Goa. This AI integration assists neuro-oncologists in selecting the most effective chemo-regimens based on tumor genetics. This helps avoid the trial-and-error approach that often delays effective treatment in such aggressive cases.
Patient Consensus: Patients emphasize the necessity of getting MGMT and IDH testing immediately at major urban centers. They often note that early palliative planning significantly improves the quality of life during the 12 to 15-month survival window.
Leading Indian hospitals like Apollo Hospital Indraprastha, Fortis Memorial Research Institute, and Manipal Hospitals specialize in complex glioblastoma care for international patients. These JCI-accredited centers utilize intraoperative MRI and neuro-navigation to maximize tumor resection while preserving vital brain functions.
Bookimed Expert Insight: Patient volume is a major quality indicator in India. Manipal Hospitals serves 2,000,000 patients annually while Global Hospital Chennai performs 18,000 annual operations. We see better outcomes at these high-volume centers. Surgeons here use linear accelerators with 1 mm accuracy for tumor irradiation.
Patient Consensus: Patients emphasize finding a neurosurgeon specifically trained in glioblastoma resection. They recommend confirming if molecular testing like IDH and MGMT status is available before starting the travel process.
Glioblastoma treatment packages in India prioritize clinical excellence and diverse therapeutic technologies. These comprehensive care models integrate advanced neurosurgery with radiation and innovative therapies. Patients access multi-disciplinary teams across hospitals accredited by JCI and NABH. Facilities offer neuro-oncology consultations and specialized diagnostics like contrast-enhanced brain MRI.
Bookimed Expert Insight: India serves as a major neuro-oncology hub with Manipal Hospitals alone treating 2,000,000 patients annually. Large networks like Apollo or Fortis provide a deeper tier of specialization for glioblastoma. They often feature proprietary research centers and AI-driven systems like IBM Watson to assist in selection. This scale allows for rapid adoption of niche treatments like Actinium-225 which are less common elsewhere.
Patient Consensus: Patients often emphasize the importance of specialized neuro-oncology expertise and high-tech diagnostics. They appreciate the detailed guidance provided by clinical teams throughout the surgical and recovery phases.